Kohei shitara (@KoheiShitara) / X

Kohei shitara (@KoheiShitara) / X

Kohei shitara (@KoheiShitara) / X

Kohei Shitara, Videos & Research

Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

Kohei Shitara, MD @KoheiShitara @theNCI @NCIResearchCtr #ASCOGI21 #GastrointestalCancer #GICancer #Cancer #Research P

Kohei shitara (@KoheiShitara) / X

Tyler Mattox, PhD (@temattox) / X

Kohei shitara (@KoheiShitara) / X

Margherita Ambrosini (@margheambro1) / X

Oncology Data Advisor - Zolbetuximab: Gastric/Gastroesophageal Junction Adenocarcinoma

Raghav Sundar (@sundar__raghav) / X

Kohei SHITARA, Chief, Department of Gastrointestinal Oncolology

Kohei SHITARA, Chief, Department of Gastrointestinal Oncolology